Associated Papers
Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin.
Torres-Ayuso P et al.
Npj Genomic Medicine, 2018
29951225 (PubMed )
Supplement: 41525_2018_55_MOESM2_ESM.xls › Sup_File_1
Thin and thick primary cutaneous melanomas reveal distinct patterns of somatic copy number alterations.
Montagnani V et al.
Oncotarget, 2016
27095580 (PubMed )
Supplement: oncotarget-07-30365-s002.pdf
Select a paper to view details